Pathways to Prevention (Protocol TN-01)
Summary
This study will help us learn more about how type 1 diabetes occurs as well as help us to identify people who may be eligible for prevention trials through screening. By ongoing monitoring, we will compare people with and without auto-antibodies to help us better understand differences over time.
Eligibility
Eligible ages: 2 to 45
Accepts healthy participants: Yes
Inclusion criteria:
- 2 to 45 years old and have a brother, sister, child, or parent with type 1 diabetes.
- 2 to 20 years old and have a cousin, aunt, uncle, niece, nephew, half-brother, half-sister, or grandparent with type 1 diabetes.
- Individuals (age 2 years - 45 years) who have diabetes related autoantibodies found though external screening
Exclusion criteria:
Individuals with Type 1 diabetes
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Heidi.Virtanen@ahs.ca 403-955-8866
Principal investigator:
Carol Huang
Clinical trial:
No
REB-ID:
REB14-2465
External links